Cargando…
Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol
INTRODUCTION: Decision models can be used to conduct economic evaluations of new pharmacogenetic and pharmacogenomic tests to ensure they offer value for money to healthcare systems. These models require a great deal of evidence, yet research suggests the evidence used is diverse and of uncertain qu...
Autores principales: | Peters, Jaime L, Cooper, Chris, Buchanan, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654339/ https://www.ncbi.nlm.nih.gov/pubmed/26560056 http://dx.doi.org/10.1136/bmjopen-2015-008465 |
Ejemplares similares
-
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature
por: Berm, Elizabeth J. J., et al.
Publicado: (2016) -
Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies
por: Richardson, Marty, et al.
Publicado: (2019) -
Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial
por: McDermott, John Henry, et al.
Publicado: (2021) -
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial
por: Hernandez-Suarez, Dagmar F, et al.
Publicado: (2020) -
Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation
por: Hayeems, Robin Z, et al.
Publicado: (2022)